Comment from Guttmacher Institute

Summary: The Guttmacher Institute, a research and policy organization, submits this comment in support of citizen petitions regarding the FDA's regulation of mifepristone. They argue that mifepristone is safe and effective, and they criticize recent efforts to restrict access based on "junk science" and misleading narratives that conflate routine care-seeking with serious medical complications.